Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy.

Abstract

BACKGROUND The role of combination therapy is poorly defined in chronic hepatitis C patients who are non-responders to interferon. AIM To assess the efficacy, safety and tolerance of interferon alfa-2b plus ribavirin in chronic hepatitis C patients who do not respond to interferon monotherapy. METHODS A total of 127 non-responder patients with chronic… (More)

Topics

  • Presentations referencing similar topics